about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateManagement of inflammatory bowel disease in pregnancyUpdated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based reviewPregnancy and Inflammatory Bowel DiseaseTreating pain during pregnancyPatterns of medication use during pregnancy in rheumatoid arthritis.Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to knowThe fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats.Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study.Treatment of acute abdominal pain in the emergency room: a systematic review of the literature.Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: A mixed-methods study.Reproductive trends in females with inflammatory joint diseaseUse of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.Modulation of Endothelial Injury Biomarkers by Traditional Chinese Medicine LC in Systemic Lupus Erythematosus Patients Receiving Standard Treatments.Therapeutic interventions employed by Greater Toronto Area chiropractors on pregnant patients: results of a cross-sectional online survey.Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives.Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.Anti-inflammatory mediators as physiological and pharmacological regulators of parturition.Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.Reproduction and autoimmune disease: important translational implications from embryo-maternal interaction.Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy.Diagnosis, pathogenesis and treatment of myositis: recent advances.Inflammatory bowel disease in women of reproductive age.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Management of Hematologic Malignancies: Special Considerations in Pregnant Women.A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis.Safety profile of biological therapies for treating rheumatoid arthritis.Treatment of rheumatoid arthritis during pregnancy: present and future.A Review of the Course and Treatment of Non-Infectious Uveitis during Pregnancy.A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes.Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study.Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma.[Pregnancy and inflammatory rheumatic diseases].Chronic pain during pregnancy: a review of the literature.
P2860
Q26744705-4ACEA1A1-2DDB-46C0-9390-7EF5802EE101Q26859134-B42E331B-313A-4A15-A9FF-435F9B4A09D6Q26865914-C561EF81-2609-4E2E-BD64-F4A05AF4E975Q27691388-911AC289-625D-4C51-9B2A-84249FBEE10EQ28388274-AB6ED1AB-A4C3-4941-B63F-7C2E9D74BDA6Q28392552-052B3966-4DA6-4668-98C0-7E55B33D44CFQ33601818-78B406AC-C608-4CF7-ACF9-48A110CC51C1Q33894177-F2A6C358-6985-4E65-8A92-8ACC9BC61473Q34389362-AE41CECB-14C7-4216-A28D-0EBAC3AC84A3Q34552050-264E0E1F-0AA0-4E9C-AB20-99AC600B77FEQ34577486-B552164F-F8F7-436B-B1F1-06CDF8CE6696Q35085907-85DCA479-B1A5-45CF-942B-D79410B63912Q35415687-304C1FC8-1D65-4BCE-BA41-372CC0DDDCF7Q35749182-1D88EE82-7A81-4515-A12B-4A0E5977700EQ36035301-2056819D-7D7E-4B21-8206-6B927A6517DDQ36446926-3F3721D2-2551-40AA-AC36-D476C258FA82Q36548651-E1D63F15-755B-410D-B0E4-D4832A5C88C4Q36866207-9E6E64D7-16AD-4556-A7BD-8B5FFB0A4C34Q37215981-236B4B88-6232-4420-990E-2FD819C92713Q37572053-E5F7A5CC-96FF-4324-98AC-A15C8D54FAA5Q37854742-F1DBFC00-F9BF-4148-9068-7EE75F212A47Q37927081-915444F8-A67E-438D-96D0-CA2BF86F1C86Q37943826-C515C8A4-6052-4A6C-9ECF-A6D742919382Q37991751-EEECFFEC-761C-4880-939D-AF76BD2B1DF2Q38119553-5FD71E6C-722E-4473-8A92-A235F518831EQ38126540-53DEE2F3-40F7-4ABA-B811-7E1A7E445903Q38131849-53F2EF21-DC96-42D8-AAC6-FCB3B38AA3DAQ38192051-4CA4D728-1020-406E-80F3-41C703FE4C67Q38234725-4D6A3351-EA20-4CC1-A3A5-5E2379B62A66Q38594889-335AE3A9-243B-4BEA-974B-8D4E3E974F3AQ38659766-B6A57975-22B9-40F4-82CD-CCB64490FEA7Q38665700-D098C428-EF8A-48FF-9A2D-F21E699ADEEFQ38832618-E62C0B09-FC7B-4F46-8144-467EDCCCB095Q38996685-3678C807-E799-46F0-98BF-912051BC3F7BQ39436705-3A038D02-59E8-4FB6-8537-8AFEA6DE8CCBQ41026313-BA0347F1-C282-42ED-95FF-95714C89D603Q43576495-C842C7E4-D22A-4877-B471-6005D280C884Q44496562-33927263-5CED-4EF1-AB41-0A4704E2A467Q55054322-0658C520-D709-40C1-8BEA-3C0DFEB87020
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of RA medications in pregnant patients.
@en
Management of RA medications in pregnant patients.
@nl
type
label
Management of RA medications in pregnant patients.
@en
Management of RA medications in pregnant patients.
@nl
prefLabel
Management of RA medications in pregnant patients.
@en
Management of RA medications in pregnant patients.
@nl
P2860
P356
P1476
Management of RA medications in pregnant patients.
@en
P2093
Frauke Förger
Monika Østensen
P2860
P2888
P304
P356
10.1038/NRRHEUM.2009.103
P407
P577
2009-06-09T00:00:00Z